Use of CSAID™ compounds as inhibitors of angiogenesis
US6372741B1 · kind B1 · utility
2Cited by
6References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 1998 |
| Grant date | Apr 16, 2002 |
| Priority date | — |
| Expiry date | Sep 8, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is to the novel use of a cytokine inhibitor, which cytokine is inhibited by the inhibition of the kinase CSBP/p38/RK, for the treatment of chronic diseases which are caused by excessive, undesired or inappropriate angiogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.